Skip to main content

Locoregional Radionuclide Cancer Therapy

Clinical and Scientific Aspects

  • Book
  • © 2021

Overview

  • Offers a comprehensive review of locoregional radionuclide cancer therapies (LRCT)
  • Includes updated scientific modeling and imaging algorithms
  • Written by experts

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (11 chapters)

Keywords

About this book

This book reviews locoregional radionuclide cancer therapies (LRCT). Proving an increasingly viable alternative to radiotherapy, radionuclide therapy includes a diversity of choices of well characterized biochemical and physiologic target molecules. The delivery and retention of radionuclides may be monitored by advanced imaging for exact tissue localization and for real-time dosimetry to enable personalized precision medicine. Radiopharmaceuticals in human cancer therapies are typically delivered in systemic routes but can also be designed for locoregional routes to harness pharmacokinetic advantages of higher payload and lower systemic toxicities. This book explores the latest advancements and clinical considerations of the locoregional approach.

Throughout the chapters, the clinical and scientific bases of cancer treatment and the locoregional use of radionculides are explored. Mathematical models of radiation dosimetry of locoregional radionculdies on tissues are studied using common models for multiple commercially available radionuclides. Rodent and canine tumor models of LRCT are compared for selected radionuclides and radiopharmaceuticals. The practical aspects of radiopharmaceuticals production, marketing, transport, as well as radiation protection are reviewed. Finally, the combination of LRCT with immunotherapy and other cancer therapies and prospective future use of LRCT are discussed.

This is a guide for practicing nuclear physicians, interventional radiologists, radiation oncologists, radiation scientists, veterinarians and oncologists to expand their knowledge base and to prepare for designing locoregional radionuclide cancer therapies in animals and in humans.


Editors and Affiliations

  • Department of Nuclear Medicine, University of Texas, M. D. Anderson Cancer Center, Houston, USA

    Franklin C.L. Wong

About the editor

Franklin C. L. Wong

University of Texas

MD Anderson Cancer Center

Houston, TX

USA


Bibliographic Information

  • Book Title: Locoregional Radionuclide Cancer Therapy

  • Book Subtitle: Clinical and Scientific Aspects

  • Editors: Franklin C.L. Wong

  • DOI: https://doi.org/10.1007/978-3-030-56267-0

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Nature Switzerland AG 2021

  • Hardcover ISBN: 978-3-030-56266-3Published: 09 December 2020

  • Softcover ISBN: 978-3-030-56269-4Published: 10 December 2021

  • eBook ISBN: 978-3-030-56267-0Published: 08 December 2020

  • Edition Number: 1

  • Number of Pages: XII, 268

  • Number of Illustrations: 20 b/w illustrations, 56 illustrations in colour

  • Topics: Nuclear Medicine, Imaging / Radiology, Internal Medicine

Publish with us